Atlas Venture Life Science Advisors, LLC
Position in DYN — Dyne Therapeutics, Inc.
CIK 1917529
CAMBRIDGE, MA
Position in DYN
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$165,535,330
-$13,056,565 QoQ
Shares Held
9,130,465
0.0% QoQ
Ownership
6.39%
of shares outstanding
% of Portfolio
20.95%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2021
18 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in DYN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Atlas Venture Life Science Advisors, LLC holds $790,032,313 across 6 Biotechnology names. DYN ranks #2 (21.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | KYMR |
Kymera Therapeutics, Inc.
|
4,578,008 | $381,302,286 | |
| 2 | DYN |
Dyne Therapeutics, Inc.
This page
|
9,130,465 | $165,535,330 | |
| 3 | SION |
Sionna Therapeutics, Inc.
|
2,995,602 | $120,093,684 | |
| 4 | IRON |
Disc Medicine, Inc.
|
1,513,875 | $96,797,167 | |
| 5 | QTTB |
Q32 Bio Inc.
|
2,092,106 | $13,431,320 | |
| 6 | KRRO |
Korro Bio, Inc.
|
1,137,149 | $12,872,526 |
All Filings in DYN
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $165,535,330 | 9,130,465 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $178,591,895 | 9,130,465 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $115,500,382 | 9,130,465 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $86,922,026 | 9,130,465 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $95,504,663 | 9,130,465 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $188,935,980 | 8,019,354 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $288,083,285 | 8,020,136 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $283,030,599 | 8,020,136 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $227,691,661 | 8,020,136 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $131,476,471 | 9,885,449 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $88,573,623 | 9,885,449 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $111,211,301 | 9,885,449 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $113,880,372 | 9,885,449 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $114,387,307 | 9,869,483 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $113,473,255 | 8,934,902 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $61,382,776 | 8,934,902 | Shares | Sole | 2022-08-03 | |
| 2022-03-31 | $86,132,455 | 8,934,902 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $106,235,984 | 8,934,902 | Shares | Sole | 2022-05-16 | |
| No filing history on record for this holder in this stock. | ||||||